Dinesh V. Ph D. Patel Sells 25,000 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX) StockZolmax • 25 days ago
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) CEO Dinesh V. Ph D. Patel sold 25,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average...
Share to Feed
This indicator may be signaling that PTGX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling PTGX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This price move could be a signal that PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...
This indicator may be signaling that PTGX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bearish indicator signaling PTGX's price could decline from here. Traders may explore shorting the stock or put options...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
This is a signal that PTGX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Protagonist Therapeutics (NASDAQ:PTGX Free Report) had its price target boosted by JPMorgan Chase Co. from $34.00 to $37.00 in a research report released on Wednesday, Benzinga reports...